跳至主要内容
临床试验/ACTRN12610000374066
ACTRN12610000374066终止未知

Prospective evaluation of all cause mortality and clinical outcome for patients with heart failure with preserved left ventricular ejection fraction.

niversity of Auckland0 个研究点目标入组 2,500 人开始时间: 2010年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
2,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Patients who either:
  • a) Present to hospital with a primary diagnosis of heart failure, or
  • b) Attend a hospital clinic for management of HF within 6 months of diagnosis

排除标准

  • Patients will be excluded from this study if:
  • a) HF is primarily due to valve disease
  • b) if the primary diagnosis is an acute coronary syndrome which has resulted in a transient episode of acute pulmonary oedema. (Note: patients with a troponin rise noted during the index admission, but in whom the main presentation is considered clinically to be HF will be included).
  • c) the patient has end stage renal failure estimated glomerular filtration rate (eGFR)<15ml/min/m2 or is receiving or planned to receive renal replacement therapy
  • d)constrictive pericarditis
  • e)other life threatening comorbidity with a life expectancy of <1 year
  • f)inability to provide informed consent
  • g)inability to comply with study protocol requirements
  • Patients who are unable to attend for follow-up will still be considered for the study even if they are not able to undertake the post discharge study visits.

研究者

发起方
niversity of Auckland

相似试验